watchdog.
Actively filingAgainst Novo Nordisk · Eli Lilly

Ozempic & GLP-1 injuries

GLP-1 drugs like Ozempic and Mounjaro are tied to severe stomach paralysis, blockages, and sudden vision loss.

Check if this may fit you
Free to checkConfidential alwaysNo obligation at any point

Where this case stands

  1. Now

    Law firms are actively signing and filing new cases right now — this is typically when review is most available.

  2. Next

    Check the criteria below. If they may fit, a firm handling this litigation can review your situation — free, and on your schedule.

What this case is about

Plaintiffs allege the makers of GLP-1 drugs failed to warn that they can cause gastroparesis (stomach paralysis), intestinal blockage, and a sudden vision-loss condition (NAION) — one of the fastest-growing dockets in the country.

Cases describe allegations that the defendants deny. Facts are drawn from public court records, settlement administrators, and litigation trackers, and can change as the case moves.

What a review will look at

  • Prescription or pharmacy records for the GLP-1 drug
  • Records confirming your diagnosis (GI study, hospital, or eye exam)
  • Dates you started and stopped the medication

Missing records aren’t a dealbreaker — legal teams help people gather them all the time.

Drugs & medical devices

Related cases we’re tracking

Actively filingDepo-Provera & brain tumorsThe Depo-Provera birth-control shot is being linked to meningioma brain tumors in long-term users.Read about this case In discoverySuboxone tooth decayThe acidic Suboxone film is alleged to destroy tooth enamel, causing decay, erosion, and tooth loss.Read about this case Trials underwayTalcum powder cancerTalc baby powder is alleged to have been contaminated with asbestos, causing ovarian cancer and mesothelioma.Read about this case

Not what you’re looking for? Browse every active case or start a general claim check.